News
When the stock market is highly volatile, many investors flock to assets that offer stability but dismal growth prospects.
Expanding Global Support: IgA Nephropathy Foundation Launches Go Global Network to Connect and Empower IgAN Patients Worldwide. By expanding our network to Canada, we are building a stronger, more ...
Detailed price information for Veeva Systems Inc (VEEV-N) from The Globe and Mail including charting and trades.
RAPT Therapeutics (RAPT) announced the appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development to oversee the ...
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with ...
Megyn Kelly, the American journalist, regrets her decision to get the Covid-19 vaccine, citing an autoimmune diagnosis ...
BOSTON -- Patients with focal segmental glomerulosclerosis (FSGS) achieved some degree of proteinuria remission more often ...
Panelists discuss how patients with immunoglobulin A (IgA) nephropathy typically present with microscopic or gross hematuria, often during upper respiratory infections, along with variable proteinuria ...
After a few more appointments and tests, it was discovered he was at 5% kidney function and diagnosed with IgA nephropathy, also known as Berger's disease, which is a chronic kidney disease ...
Scotiabank analyst Greg Harrison lowered the firm’s price target on Travere Therapeutics (TVTX) to $30 from $32 and keeps an ...
Richard Lafayette, MD, FACP, Stanford University Medical Center, explains the significance of this second approval in a month ...
Adults recently diagnosed with immunoglobulin A nephropathy who were assigned sparsentan as first-line therapy experienced rapid and sustained reductions in proteinuria, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results